Dr. Raymond N. DuBois is a renowned physician-scientist and cancer researcher who has made significant contributions to understanding the role of inflammation and inflammatory mediators in the progression of colon cancer and other gastrointestinal malignancies. His work has led to a better understanding of the molecular basis for anti-inflammatory agents, such as aspirin, in reducing cancer risk. It has also led to clinical trials showing how drugs that inhibit this pathway could prevent or intercept the cancerization process.
Dr. DuBois has published over 160 peer-reviewed research articles out of a total of 274 publications, more than 72 review articles, 25 book chapters, and three books during his career, and his work has been cited over 66,000 times. He is also a co-inventor of a method to identify and target cellular genes needed for viral growth and cellular genes that function as tumor suppressors in mammals, which led to the creation of a biotech company that utilized this technology as a platform to discover new drug targets for the treatment of cancer and viral infections.
He has been recognized with numerous awards for his cancer research, including the Richard and Hinda Rosenthal Research Award, the Dorothy P. Landon-AACR Cancer Prize, the Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research, the AACR Distinguished Service Award, and the Anthony Dipple Carcinogenesis Award from Oxford University Press. He was inducted as a member of the National Academy of Medicine in 2019 and is a Fellow of the American Association for the Advancement of Science, the Academy of the American Association for Cancer Research, the American Gastroenterology Association, and the Royal College of Physicians. In addition, he currently holds the positions of executive chair of the Board of Directors of the Mark Foundation for Cancer Research and vice chair of the Stand Up to Cancer Foundation.
Dr. DuBois earned a bachelor’s degree in biochemistry with honors from Texas A&M University, a PhD in biochemistry from The University of Texas Southwestern Medical Center, and a medical degree from The University of Texas School of Medicine in San Antonio. In addition, he completed his internship/residency in medicine and a gastroenterology fellowship at the Johns Hopkins Hospital, where he studied under Nobel Laureate Daniel Nathans as a Howard Hughes Research Associate. He has previously served as director of the Vanderbilt-Ingram Cancer Center, provost and EVP at The University of Texas MD Anderson Cancer Center, executive director of the Arizona Biodesign Institute at Arizona State University, and president of the American Association for Cancer Research.